Board of Trustees of The Leland Stanford Junior University’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Board of Trustees of The Leland Stanford Junior University’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-12,067	Closed	-$480K	–	53
2014 Q1	$480K	Buy	+12,067	New	+$540K	0.18%	43

Other funds holding KYTH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University's KYTH Position: Q2 2014 in Review

Board of Trustees of The Leland Stanford Junior University sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q2 2014, closing a stake of 12,067 shares — an estimated $480K sold.

Board of Trustees of The Leland Stanford Junior University first reported a position in KYTH in Q1 2014 and held it in 1 quarter. The position peaked at $480K in Q1 2014. 104 funds tracked by Wall St. Rank hold KYTH as of Q2 2014.

Board of Trustees of The Leland Stanford Junior University reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q2 2014 after selling out during the quarter.
Board of Trustees of The Leland Stanford Junior University sold 12,067 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q2 2014, an estimated $480K.
Board of Trustees of The Leland Stanford Junior University first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q1 2014 and held it in 1 quarter.
Board of Trustees of The Leland Stanford Junior University's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $480K in Q1 2014.
104 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q2 2014.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q2 2014, filed 12 Aug 2014.